Correspondence and General Collaboration Papers 1998

Clinical trial data, Scientific Advisory Board meeting correspondence, meeting administration, article reprints, T22 draft manuscript, patent correspondence, manuscript correspondence, royalty discussions, Arthritis Research Campaign (ARC) correspondence, summary of patents applied for at the Kennedy Institute, continued correspondence relating to Remicade trials, FDA approval of Remicade and discussions with Hubert Schoemaker.

See SA/KET/A/2/1 for an overview of the Centocor correspondence, general papers and list of main correspondence contributors.

See SA/KET/A/1 for papers on Centocor sponsored clinical studies/trials.

Item contains some duplicate correspondence.

1998

1 file (in 2 parts)

This item is held in offsite storage and requires a longer time for delivery. This item is also restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2059.